Durable molecular complete remission induced by low-dose imatinib plus low-dose interferon alpha in a patient with chronic myelogenous leukaemia.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/79CDDDC2.svg?ark=w1%2F20260515%2F79CDDDC2)](https://nobleid.org/work/w1/20260515/79CDDDC2)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors